OptimizeRx Corporation (OPRX)

[4retire]

It's a travesty that a near miss on a quarterly report would cause a 30% drop in the value of this company. It was either highly inflated or people are losing patience in the management to control costs while following their growth strategies.

For example, was there a need to add 32 more sales/marketing personnel this past quarter? There probably was. But, as such, they cannot have less than a stellar fourth quarter in sales and increased profitability. Growth with the absence of profit is dooming to any equity.